Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Eczema other diagnostic studies
Introduction
Overview
Overview
No particular biomarker is reliable to diagnose eczema. However, potential options include CD30, macrophage-derived chemoattractant (MDC}, thymus and activation-regulated cytokine (TARC), and interleukin-12 (IL-12) ,interleukin-16 (IL-16, interleukin-18 (IL-18), and interleukin-31 (IL-31).[1] [2] [3] [4]
Other Diagnostic Studies of Eczema
Other Diagnostic Studies of Eczema
- No particular biomarker is reliable to diagnose eczema.
- However, potential options include:
- CD30
- Macrophage-derived chemoattractant (MDC)
- Thymus and activation-regulated cytokine (TARC)
- Interleukin-12 (IL-12)
- Interleukin-16 (IL-16)
- Interleukin-18 (IL-18)
- interleukin-31 (IL-31).
References
References
- ↑ Eichenfield LF, Tom WL, Chamlin SL, Feldman SR, Hanifin JM, Simpson EL; et al. (2014). “Guidelines of care for the management of atopic dermatitis: section 1. Diagnosis and assessment of atopic dermatitis”. J Am Acad Dermatol. 70 (2): 338–51. doi:10.1016/j.jaad.2013.10.010. PMC 4410183. PMID 24290431.
- ↑ Kabashima K (2013). “New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity”. J Dermatol Sci. 70 (1): 3–11. doi:10.1016/j.jdermsci.2013.02.001. PMID 23473856.
- ↑ Murat-Susić S, Lipozencić J, Zizić V, Husar K, Marinović B (2006). “Serum eosinophil cationic protein in children with atopic dermatitis”. Int J Dermatol. 45 (10): 1156–60. doi:10.1111/j.1365-4632.2006.02865.x. PMID 17040428.
- ↑ Schulte-Herbrüggen O, Fölster-Holst R, von Elstermann M, Augustin M, Hellweg R (2007). “Clinical relevance of nerve growth factor serum levels in patients with atopic dermatitis and psoriasis”. Int Arch Allergy Immunol. 144 (3): 211–6. doi:10.1159/000103994. PMID 17579279.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.